check_circleStudy Completed
Magnetic Resonance Imaging
Bayer Identifier:
Trial_202-14_88492
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Gadopentetate Dimeglumine as a magnetic resonance imaging (MRI) contrast agent in pediatric patients with symptoms of central nervous system (CNS) lesions
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
20Trial Dates
July 1987 - December 1987Phase
Phase 3Could I Receive a placebo
N/AProducts
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A